Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance
Hongzhi Wang, Satheesh Ellipilli, Wen-Jui Lee, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 173-184
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
Hailong Tian, Tingting Zhang, Siyuan Qin, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 239
Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis
Mengnan Zhao, Rujing Wang, Kunmeng Yang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 3, pp. 916-941
Open Access | Times Cited: 84
Overview and countermeasures of cancer burden in China
Yian Wang, Qijia Yan, Chunmei Fan, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 11, pp. 2515-2526
Open Access | Times Cited: 79
The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy
Shangui Liu, Abdur Rauf Khan, Xiaoye Yang, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 1-20
Closed Access | Times Cited: 96
Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine—Specific Cancer Targeting with Undetectable Toxicity
Daniel W. Binzel, Xin Li, Nicolas Burns, et al.
Chemical Reviews (2021) Vol. 121, Iss. 13, pp. 7398-7467
Open Access | Times Cited: 65
Emerging nanomedicines of paclitaxel for cancer treatment
Qin Chen, Shu Xu, Shuo Liu, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 280-294
Closed Access | Times Cited: 63
Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives
Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 29
Ligand-displaying-exosomes using RNA nanotechnology for targeted delivery of multi-specific drugs for liver cancer regression
Satheesh Ellipilli, Hongzhi Wang, Daniel W. Binzel, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 50, pp. 102667-102667
Open Access | Times Cited: 23
Co-delivery of camptothecin and MiR-145 by lipid nanoparticles for MRI-visible targeted therapy of hepatocellular carcinoma
Rong Jing, Tongtong Liu, Xiujuan Yin, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 11
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy
Chunbao Zang, Yu Tian, Yujing Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Designing Multivalent Aptamers: Recent Advancements in Diagnostic and Therapeutic Approaches for Cancer Treatment
Zahra Moradi, Khalil Abnous, Seyed Mohammad Taghdisi, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106614-106614
Closed Access | Times Cited: 1
Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome
Nasir Uddin, Daniel W. Binzel, Dan Shu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 4, pp. 1383-1399
Open Access | Times Cited: 34
GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma
Yanying Li, Jingliang Wu, Lu Qiao, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 2559-2575
Open Access | Times Cited: 30
The application of nanoparticles in immunotherapy for hepatocellular carcinoma
Xinyao Hu, Hua Zhu, Xiaoqin He, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 85-108
Closed Access | Times Cited: 19
RNA nanostructures for targeted drug delivery and imaging
Laura Teodori, Marjan Omer, Jørgen Kjems
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-19
Open Access | Times Cited: 7
Engineered exosomes loaded with M1–8 peptide for targeted therapy of hepatocellular carcinoma
Rui Deng, Jibin Wu, Baokang Zhu, et al.
Applied Materials Today (2024) Vol. 37, pp. 102071-102071
Open Access | Times Cited: 6
Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
Michelle K. Greene, Michael C. Johnston, Christopher J. Scott
Cancers (2021) Vol. 13, Iss. 24, pp. 6175-6175
Open Access | Times Cited: 40
The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development
Xin Li, Abhjeet S. Bhullar, Daniel W. Binzel, et al.
Advanced Drug Delivery Reviews (2022) Vol. 186, pp. 114316-114316
Open Access | Times Cited: 26
Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models
Vilma Petrikaitė, Nicola d’Avanzo, Christian Celia, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100956-100956
Closed Access | Times Cited: 14
In Vitro and In Vivo Evaluation of the Pathology and Safety Aspects of Three- and Four-Way Junction RNA Nanoparticles
Kai Jin, You-Cheng Liao, Tzu‐Chun Cheng, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 718-728
Closed Access | Times Cited: 5
Posterior eye delivery of angiogenesis-inhibiting RNA nanoparticles via subconjunctival injection
Cheng Zhong, Zhanquan Shi, Daniel W. Binzel, et al.
International Journal of Pharmaceutics (2024) Vol. 657, pp. 124151-124151
Closed Access | Times Cited: 5
Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
Janitha M. Unagolla, Subarna Das, Riley Flanagan, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124381-124381
Closed Access | Times Cited: 5
Inhibition of Endothelial Cell Tube Formation by Anti-Vascular Endothelial Growth Factor/Anti-Angiopoietin-2 RNA Nanoparticles
Cheng Zhong, Zhanquan Shi, Chia‐Yang Liu, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 55-55
Open Access
Targeted delivery of cancer drug paclitaxel to chordomas tumor cells via an RNA nanoparticle harboring an EGFR aptamer
Dan Xiao, Yongxiong Huang, Shuaihao Huang, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 212, pp. 112366-112366
Closed Access | Times Cited: 19
Dynamic RNA synthetic biology: new principles, practices and potential
Yueyi Li, Aníbal Arce, Tyler Lucci, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 817-829
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top